0001104659-18-017201.txt : 20180313
0001104659-18-017201.hdr.sgml : 20180313
20180313181540
ACCESSION NUMBER: 0001104659-18-017201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180313
DATE AS OF CHANGE: 20180313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sabba Stephen L
CENTRAL INDEX KEY: 0001442372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 18687814
MAIL ADDRESS:
STREET 1: DORSET MANAGEMENT CORP
STREET 2: 485 UNDERHILL BLVD SUITE 205
CITY: SYOSSET
STATE: NY
ZIP: 11791
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
a4.xml
4
X0306
4
2018-03-12
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001442372
Sabba Stephen L
DORSET MANAGEMENT CORP
485 UNDERHILL BLVD SUITE 205
SYOSSET
NY
11791
1
0
0
0
Common Stock
2018-03-12
4
S
0
622
180.73
D
26363
D
These securities, as represented in Column 5, include a grant of 666 restricted shares approved by the Board of Directors of the Company at the 2017 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.
/s/ Stephen L. Sabba
2018-03-13